Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.570
-0.060 (-3.68%)
At close: Feb 21, 2025, 4:00 PM
1.530
-0.040 (-2.55%)
After-hours: Feb 21, 2025, 7:58 PM EST

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Net Income
-33.01-39.26-28.26-8.52-3.78-0.85
Upgrade
Depreciation & Amortization
----00
Upgrade
Stock-Based Compensation
1.473.410.180.15--
Upgrade
Other Operating Activities
-0.80.240.19-1.592.05-0.01
Upgrade
Change in Accounts Payable
3.50.333.01-0.50.780.16
Upgrade
Change in Other Net Operating Assets
-4.486.965.92-0.2-3.10.48
Upgrade
Operating Cash Flow
-33.32-28.32-18.96-10.67-4.07-0.22
Upgrade
Short-Term Debt Issued
-0.67--3.110.1
Upgrade
Total Debt Issued
0.420.67--3.110.1
Upgrade
Short-Term Debt Repaid
--0.67----
Upgrade
Total Debt Repaid
-0.55-0.67----
Upgrade
Net Debt Issued (Repaid)
-0.14---3.110.1
Upgrade
Issuance of Common Stock
34.0533.177.7931.69.72-
Upgrade
Financing Cash Flow
33.9133.177.7931.612.830.1
Upgrade
Net Cash Flow
0.594.85-11.1720.938.76-0.12
Upgrade
Free Cash Flow
-33.32-28.32-18.96-10.67-4.07-0.22
Upgrade
Free Cash Flow Per Share
-1.10-1.19-0.97-0.72-1.33-0.08
Upgrade
Cash Interest Paid
0.020.03--0.33-
Upgrade
Cash Income Tax Paid
---000
Upgrade
Levered Free Cash Flow
-16.06-13.99-8.54-6.87-4.151.3
Upgrade
Unlevered Free Cash Flow
-16.06-13.99-8.54-6.87-3.241.59
Upgrade
Change in Net Working Capital
-3.8-7.28-8.930.71.72-1.83
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.